Artifoni M.,Danic G.,Gautier G.,Gicquel P.,Boutoille D.,Raffi F.,Lecomte R. .2020 .Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors. Journal of Thrombosis and Thrombolysis, 50 : 211-216.
de Meira Leite M.,Gonzalez-Galarza F. F.,da Silva B. C. C.,Middleton D.,Dos Santos E. J. M. .2021 .Predictive immunogenetic markers in COVID-19. , 82(4) : 247-254.
Marin Gallo,Aghagoli B.,Lavine G.,Yang K.,Siff L.,Chiang E. J.,Michelow S. S.,I. C. S. S. .2021 .Predictors of COVID-19 severity: a literature review. Reviews in Medical Virology, 31(1) : 1-10.
Ma H.,Li Q.,Liu C.,Zhao R.,Wang L.,Xia W.,Y. W. .2020 .Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerging Microbes & Infections, 9(1) : 1123-1130.
Hasty F.,García G.,Dávila H.,Wittels S. H.,Hendricks S.,Chong S. .2021 .Heart rate variability as a possible predictive marker for acute inflammatory response in COVID-19 patients. Military Medicine, 186(1- 2) : e34-e38.
Qin J. J,Zhou F.,Lei F.,Akolkar G.,Cai J.,Li H. .2020 .Redefining cardiac biomarkers in predicting mortality of inpatients with COVID-19. , 76(4) : 1104-1112.
Sugiyama M.,Kinoshita N.,Ide S.,Nomoto H.,Nakamoto T.,Saito S.,Mizokami M. .2021 .Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19. , 766 : 145145.
Yan L.,Zhang L.,Goncalves J.,Xiao Y.,Wang M.,Guo Y.,Yuan Y. .2020 .An interpretable mortality prediction model for COVID19 patients. Nature Machine Intelligence, 2(5) : 283-288.
Asghar M. S.,Kazmi S. J. H.,Khan N. A.,Akram M.,Hassan M.,Rasheed U.,Khan S. A. .2020 .Poor prognostic biochemical markers predicting fatalities caused by COVID-19: a retrospective observational study from a developing country. Cureus, 12(8) : .
Del Valle D. M.,Kim-Schulze S.,Huang H. H.,Beckmann N. D.,Nirenberg S.,Wang B.,Gnjatic S. .2020 .An inflammatory cytokine signature predicts COVID-19 severity and survival. Nature Medicine, 26(10) : 1636-1643.
Goshua G.,Pine A. B.,Meizlish M. L.,Chang C. H.,Bahel P.,Lee A. I. .2020 .Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. The Lancet Haematology, 7(8) : e575-e582.
Harmouch F.,Shah K.,Hippen J. T.,Kumar A.,Goel H. .2021 .Is it all in the heart? Myocardial injury as major predictor of mortality among hospitalized COVID-19 patients. Journal of Medical Virology, 93(2) : 973-982.
Kuluöztürk M.,In M.,Telo S.,Karabulut E.,Geçkil A. A. .2021 .Efficacy of copeptin in distinguishing COVID-19 pneumonia from community-acquired pneumonia. Journal of Medical Virology, 93(5) : 3113-3121.
Philippe A.,Chocron R.,Gendron N.,Bory O.,Beauvais A.,Peron N.,Smadja D. M. .2021 .Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis, 1 : 13.
Shang W.,Dong J.,Ren Y.,Tian M.,Li W.,Hu J.,Li Y. .2020 .The value of clinical parameters in predicting the severity of COVID-19. Journal of Medical Virology, 92(10) : 2188-2192.
Çakır I.,Günay N. E.,Pangal D.,Sert G. A.,Duru N. .2020 .Monocyte to High-Density Lipoprotein Ratio: A Novel Inflammation Marker Related to Diabetic Retinopathy. Erciyes Medical Journal/Erciyes Tip Dergisi, 42(2) : 190-5.
Davidson W. S.,Shah A. S. .2019 .High-density lipoprotein subspecies in health and human disease: focus on type 2 diabetes. Methodist DeBakey Cardiovascular Journal, 15(1) : 55-61.
Haghikia A.,Landmesser U. .2018 .High-density lipoproteins: effects on vascular function and role in the immune response. Cardiology Clinics, 36(2) : 317-327.
Karatas A.,Turkmen E.,Erdem E.,Dugeroglu H.,Kaya Y. .2018 .Monocyte to high-density lipoprotein cholesterol ratio in patients with diabetes mellitus and diabetic nephropathy. Biomarkers in Medicine, 12(9) : 953-959.
Rye K. A. .2013 .High density lipoprotein structure, function, and metabolism: a new Thematic Series. Journal of Lipid Research, 54(8) : 2031-2033.
Rizzo P.,Fortini F.,Marracino F.,Rapezzi L.,Ferrari C.,R. C. .2020 .COVID-19 in the heart and the lungs: could we “Notch” the inflammatory storm?. , 115 : 1-8.
Zheng Y. Y.,Ma Y. T.,Zhang J. Y.,Xie X. .2020 .COVID-19 and the cardiovascular system. Nature reviews cardiology, 17(5) : 259-260.
Tan W.,Aboulhosn J. .2020 .The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease. International journal of Cardiology, 309 : 70-77.
Wang D.,Hu B.,Hu C.,Zhu F.,Liu X.,Zhang X.,Peng Z. .2020 .Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. , 323(11) : 1061-1069.
Li Z.,Yang T.,Han D.,Mi X.,Li Y.,Guo X. .2020 .Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain. Frontiers of Medicine, 14 : 533-541.
Sun J.,Aghemo A.,Forner A.,Valenti L. .2020 .COVID-19 and liver disease. Liver International, 40(6) : 1278-1281.
Zhang C.,Shi L.,Wang F. S. .2020 .Liver injury in COVID-19: management and challenges. The Lancet Gastroenterology & Hepatology, 5(5) : 428-430.
Luo Y.,Wang R.,Zhang K.,Wang M.,Dong Z.,Xu L.,G. L. .2020 .Kidney disease is associated with in-hospital death of patients with COVID-19. , 97(5) : 829-838.
Naicker S.,Yang C. W.,Hwang S. J.,Liu B. C.,Chen J. H.,Jha V. .2020 .The novel coronavirus 2019 epidemic and kidneys. , 97(5) : 824-828.
Chen N.,Zhou M.,Dong X.,Qu J.,Gong J.,Han Y.,Zhang L. .2020 .Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 395(10223) : 507-513.
Wu T. T.,Zheng Y. Y.,Chen Y.,Yu Z. X.,Ma Y. T.,Xie X. .2019 .Monocyte to high-density lipoprotein cholesterol ratio as longterm prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention. Lipids in Health and Disease, 18 : 1-10.
Demirbas ¸,Elmas A.,Atasoy Ö. F.,Türsen M.,Lotti T. .2021 .Can monocyte to HDL cholesterol ratio and monocyte to lymphocyte ratio be markers for inflammation and oxidative stress in patients with vitiligo? A preliminary study. Archives of Dermatological Research, 313 : 491-498.
Canpolat U.,Çetin E. H.,Cetin S.,Aydin S.,Akboga M. K.,Yayla C.,Aydogdu S. .2016 .Association of monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation. Clinical and Applied Thrombosis/Hemostasis, 22(5) : 476-482.
Mirza Z.,Oltulu E.,Katipoglu R.,B. R. .2020 .May monocyte/HDL cholesterol ratio (MHR) and neutrophil/lymphocyte ratio (NLR) be an indicator of inflammation and oxidative stress in patients with keratoconus?. Ocular Immunology and Inflammation, 28(4) : 632-636.
Devaraj S.,Vega G.,Lange R.,Grundy S. M.,Jialal I. .1998 .Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease. The American Journal of Medicine, 104(5) : 445-450.
Kucur M.,Isman F. K.,Karadag B.,Vural V. A.,Tavsanoglu S. .2007 .Serum YKL-40 levels in patients with coronary artery disease. Coronary Artery Disease, 18(5) : 391-396.
Lichtman J. H.,Amatruda J.,Yaari J.,Smith G. L.,Mattera J. A.,Krumholz H. M. .2004 .Clinical trial of an educational intervention to achieve recommended cholesterol levels in patients with coronary artery disease. American Heart Journal, 147(3) : 522-528.
Sachdeva A.,Cannon C. P.,Deedwania P. C.,LaBresh K. A.,Smith Jr S. C.,Dai D.,Fonarow G. C. .2009 .Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. American Heart Journal, 157(1) : 111-117.
Hu X.,Chen D.,Wu L.,He G.,Ye W. .2020 .Low serum cholesterol level among patients with COVID-19 infection in Wenzhou, China. China (February, 21 : .